Live Quote · NASDAQEYPTHealthcare· Biotechnology

EyePoint Pharmaceuticals, Inc.

$13.98 5.95%(+$0.79)
TickerSpark Score
47/100
Weak
50
Valuation
40
Profitability
10
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EYPT research report →

52-Week Range47% of range
Low
$9.40
Current
$13.98
High
$19.11
Company Overvieweyepointpharma.com

About the company

EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom.

CEO
Jay S. Duker
IPO
2005
Employees
165
HQ
Watertown, MA, US

Price Chart

+44.72% · this period
$18.85$14.17$9.49Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.17B
P/E
-3.99
P/S
153.92
P/B
5.22
EV/EBITDA
-4.29
Div Yield
0.00%
Profitability
Gross Margin
76.51%
Op Margin
-3700.89%
Net Margin
-3566.63%
ROE
-110.54%
ROIC
-112.37%
Growth & Income
Revenue
$31.37M · -27.50%
Net Income
$-231,962,000 · -77.25%
EPS
$-3.17 · -36.64%
Op Income
$-243,434,000
FCF YoY
-86.82%
Performance & Tape
52W High
$19.11
52W Low
$9.40
50D MA
$13.17
200D MA
$14.13
Beta
1.75
Avg Volume
1.07M

Get TickerSpark's AI analysis on EYPT

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 30, 26Ribeiro Ramiroother2,437
Jun 30, 26Ribeiro Ramiroother2,438
Jun 30, 26Ribeiro Ramiroother2,438
Jun 30, 26Ribeiro Ramirosell2,437
Jun 30, 26Ribeiro Ramiroother2,437
Jun 30, 26Ribeiro Ramirosell2,438
May 25, 26Elston Georgeother7,500
May 25, 26Elston Georgeother3,627
May 25, 26Elston Georgeother7,500
Apr 17, 26Ribeiro Ramiroother2,437
Coverage · EYPT

Our EYPT coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on EYPT yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate EYPT report →
Internal Compare

Similar companies

Peers in the same neighborhood.